Home ETF List About

Portfolio Holdings Detail for ISIN IE0003WV2ME7
Stock Name / FundiShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity Type
Entity LEI 549300PZLRJB7M8H1057
ETF TickerISPE(GBP) LSE
ETF TickerISPE.L(GBP) LSE

Holdings detail for INCY

Stock NameIncyte Corporation
TickerINCY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45337C1027
LEI549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib
(RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update
Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY)
Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00
Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY)
Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC
Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY)
Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY)
Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC
Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY)
Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY)
State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY)
Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY)
Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY)
Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus
Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc) INCY holdings

DateNumber of INCY Shares HeldBase Market Value of INCY SharesLocal Market Value of INCY SharesChange in INCY Shares HeldChange in INCY Base ValueCurrent Price per INCY Share HeldPrevious Price per INCY Share Held
2025-11-11 (Tuesday)88,473INCY holding decreased by -62USD 9,569,240INCY holding increased by 186301USD 9,569,240-62USD 186,301 USD 108.16 USD 105.98
2025-11-10 (Monday)88,535USD 9,382,939USD 9,382,9390USD 0 USD 105.98 USD 105.98
2025-11-07 (Friday)88,535INCY holding increased by 434USD 9,382,939INCY holding increased by 114714USD 9,382,939434USD 114,714 USD 105.98 USD 105.2
2025-11-06 (Thursday)88,101USD 9,268,225INCY holding decreased by -44051USD 9,268,2250USD -44,051 USD 105.2 USD 105.7
2025-11-05 (Wednesday)88,101INCY holding decreased by -4216USD 9,312,276INCY holding decreased by -188990USD 9,312,276-4,216USD -188,990 USD 105.7 USD 102.92
2025-11-04 (Tuesday)92,317USD 9,501,266INCY holding increased by 124628USD 9,501,2660USD 124,628 USD 102.92 USD 101.57
2025-11-03 (Monday)92,317USD 9,376,638INCY holding increased by 746845USD 9,376,6380USD 746,845 USD 101.57 USD 93.48
2025-10-31 (Friday)92,317USD 8,629,793INCY holding increased by 82162USD 8,629,7930USD 82,162 USD 93.48 USD 92.59
2025-10-30 (Thursday)92,317USD 8,547,631INCY holding increased by 222484USD 8,547,6310USD 222,484 USD 92.59 USD 90.18
2025-10-29 (Wednesday)92,317INCY holding decreased by -3379USD 8,325,147INCY holding decreased by -445391USD 8,325,147-3,379USD -445,391 USD 90.18 USD 91.65
2025-10-28 (Tuesday)95,696USD 8,770,538INCY holding decreased by -136846USD 8,770,5380USD -136,846 USD 91.65 USD 93.08
2025-10-27 (Monday)95,696USD 8,907,384INCY holding increased by 172253USD 8,907,3840USD 172,253 USD 93.08 USD 91.28
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE0003WV2ME7

Show aggregate share trades of INCY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-11SELL-62108.670105.530 105.844USD -6,562 71.77 Loss of -2,113 on sale
2025-11-07BUY434106.400103.810 104.069USD 45,166 71.47
2025-11-05SELL-4,216106.470101.500 101.997USD -430,019 71.16 Loss of -130,000 on sale
2025-10-29SELL-3,37990.18094.420 93.996USD -317,612 70.59 Loss of -79,092 on sale
2025-10-24SELL-68091.28092.080 92.000USD -62,560 70.29 Loss of -14,763 on sale
2025-10-23SELL-12689.31089.560 89.535USD -11,281 70.20 Loss of -2,436 on sale
2025-10-22BUY18988.06088.210 88.195USD 16,669 70.12
2025-10-20SELL-2,20586.17087.950 87.772USD -193,537 69.96 Loss of -39,275 on sale
2025-10-16SELL-31587.31092.860 92.305USD -29,076 69.88 Loss of -7,065 on sale
2025-10-15SELL-78188.15088.490 88.456USD -69,084 69.79 Loss of -14,578 on sale
2025-10-03BUY25286.85086.980 86.967USD 21,916 69.54
2025-10-02SELL-2,52086.28088.660 88.422USD -222,823 69.46 Loss of -47,778 on sale
2025-10-01SELL-2,40686.70087.240 87.186USD -209,770 69.38 Loss of -42,846 on sale
2025-09-30SELL-6384.81085.310 85.260USD -5,371 69.30 Loss of -1,005 on sale
2025-09-29SELL-82883.89084.410 84.358USD -69,848 69.23 Loss of -12,526 on sale
2025-09-26SELL-6382.70082.950 82.925USD -5,224 69.16 Loss of -867 on sale
2025-09-25BUY81981.66084.450 84.171USD 68,936 69.10
2025-09-24SELL-21,96384.16084.820 84.754USD -1,861,452 69.02 Loss of -345,468 on sale
2025-09-18BUY15086.00086.070 86.063USD 12,909 68.94
2025-08-18BUY13884.92087.240 87.008USD 12,007 68.62
2025-08-12SELL-7581.61081.820 81.799USD -6,135 68.28 Loss of -1,014 on sale
2025-07-29BUY8077.38077.870 77.821USD 6,226 68.14
2025-07-23SELL-22570.69070.830 70.816USD -15,934 68.11 Loss of -610 on sale
2025-07-22SELL-45668.90069.120 69.098USD -31,509 68.10 Loss of -455 on sale
2025-07-21SELL-15267.38068.630 68.505USD -10,413 68.11 Loss of -61 on sale
2025-07-18SELL-38067.86069.430 69.273USD -26,324 68.11 Loss of -443 on sale
2025-07-15SELL-15268.25070.150 69.960USD -10,634 68.09 Loss of -284 on sale
2025-07-14SELL-37569.98070.040 70.034USD -26,263 68.08 Loss of -731 on sale
2025-07-11SELL-22568.59069.970 69.832USD -15,712 68.08 Loss of -394 on sale
2025-07-10SELL-90070.34070.620 70.592USD -63,533 68.07 Loss of -2,271 on sale
2025-07-09SELL-30068.72069.300 69.242USD -20,773 68.06 Loss of -353 on sale
2025-07-08SELL-97567.67068.650 68.552USD -66,838 68.07 Loss of -473 on sale
2025-07-03SELL-1,29268.45068.960 68.909USD -89,030 68.07 Loss of -1,088 on sale
2025-07-02SELL-23168.17069.100 69.007USD -15,941 68.07 Loss of -217 on sale
2025-06-30BUY3,27768.10068.820 68.748USD 225,287 68.07
2025-06-27SELL-3,62668.37071.120 70.845USD -256,884 68.06 Loss of -10,083 on sale
2025-06-25BUY7467.55069.140 68.981USD 5,105 68.05
2025-06-24SELL-2,73869.01069.540 69.487USD -190,255 68.04 Loss of -3,948 on sale
2025-06-23SELL-7467.26068.780 68.628USD -5,078 68.05 Loss of -43 on sale
2025-06-20BUY14868.46069.190 69.117USD 10,229 68.05
2025-06-18SELL-44468.27069.470 69.350USD -30,791 68.04 Loss of -580 on sale
2025-06-17BUY3,27168.81070.890 70.682USD 231,201 68.04
2025-06-11SELL-21668.85070.360 70.209USD -15,165 68.03 Loss of -471 on sale
2025-06-10SELL-50470.07070.980 70.889USD -35,728 68.01 Loss of -1,449 on sale
2025-06-06SELL-14468.77068.980 68.959USD -9,930 68.00 Loss of -139 on sale
2025-06-05SELL-1,22467.24067.870 67.807USD -82,996 68.00 Profit of 238 on sale
2025-06-02SELL-5,83265.31065.970 65.904USD -384,352 68.03 Profit of 12,396 on sale
2025-05-30SELL-1,29665.06065.770 65.699USD -85,146 68.05 Profit of 3,046 on sale
2025-05-29SELL-14466.04066.260 66.238USD -9,538 68.06 Profit of 263 on sale
2025-05-27SELL-14465.35065.800 65.755USD -9,469 68.10 Profit of 338 on sale
2025-05-23SELL-21664.25064.570 64.538USD -13,940 68.16 Profit of 782 on sale
2025-05-16SELL-1,08063.31063.480 63.463USD -68,540 68.29 Profit of 5,217 on sale
2025-05-15SELL-21662.76062.990 62.967USD -13,601 68.33 Profit of 1,159 on sale
2025-05-13SELL-7260.81061.150 61.116USD -4,400 68.44 Profit of 527 on sale
2025-05-12SELL-50460.85061.410 61.354USD -30,922 68.50 Profit of 3,601 on sale
2025-05-09SELL-43258.98060.480 60.330USD -26,063 68.57 Profit of 3,559 on sale
2025-05-08SELL-2,08859.73059.990 59.964USD -125,205 68.64 Profit of 18,107 on sale
2025-05-07SELL-14459.55060.070 60.018USD -8,643 68.70 Profit of 1,251 on sale
2025-05-06BUY4859.61062.510 62.220USD 2,987 68.77
2025-05-01BUY2,73662.03062.640 62.579USD 171,216 68.93
2025-04-30BUY1,51262.66062.870 62.849USD 95,028 68.98
2025-04-29SELL-28860.43060.720 60.691USD -17,479 69.04 Profit of 2,406 on sale
2025-04-28SELL-35059.52059.600 59.592USD -20,857 69.12 Profit of 3,335 on sale
2025-04-25BUY14459.16059.210 59.205USD 8,526 69.20
2025-04-24SELL-7258.97059.050 59.042USD -4,251 69.28 Profit of 737 on sale
2025-04-22SELL-9,64857.38058.040 57.974USD -559,333 69.48 Profit of 110,972 on sale
2025-04-17SELL-4,39258.21058.690 58.642USD -257,556 69.77 Profit of 48,894 on sale
2025-04-16BUY14457.73058.780 58.675USD 8,449 69.88
2025-04-15BUY14458.46059.950 59.801USD 8,611 69.98
2025-04-10SELL-4,53655.17058.330 58.014USD -263,152 70.32 Profit of 55,811 on sale
2025-04-09BUY36058.86059.370 59.319USD 21,355 70.42
2025-04-08BUY7256.97061.470 61.020USD 4,393 70.54
2025-04-07BUY1,27860.29061.060 60.983USD 77,936 70.63
2025-04-04BUY78160.58063.570 63.271USD 49,415 70.73
2025-04-02BUY49762.33062.530 62.510USD 31,067 70.80
2025-04-01BUY5,68760.91062.000 61.891USD 351,974 70.90
2025-03-31BUY21660.55060.810 60.784USD 13,129 70.99
2025-03-25BUY7262.08063.270 63.151USD 4,547 71.38
2025-03-20BUY14460.58061.750 61.633USD 8,875 71.67
2025-03-18BUY36060.00061.030 60.927USD 21,934 71.91
2025-03-17BUY4762.01063.450 63.306USD 2,975 72.01
2025-03-14SELL-2567.86068.120 68.094USD -1,702 72.06 Profit of 99 on sale
2025-03-13SELL-4,64567.71068.970 68.844USD -319,780 72.10 Profit of 15,135 on sale
2025-03-12BUY86467.73068.230 68.180USD 58,908 72.15
2025-03-11BUY86468.07071.650 71.292USD 61,596 72.19
2025-03-07BUY28870.79072.810 72.608USD 20,911 72.22
2025-03-06BUY1,00870.09070.980 70.891USD 71,458 72.25
2025-03-05BUY5,47269.81069.970 69.954USD 382,788 72.27
2025-03-04BUY28869.68070.000 69.968USD 20,151 72.30
2025-03-03BUY36070.26073.450 73.131USD 26,327 72.33
2025-02-28BUY72073.50073.630 73.617USD 53,004 72.31
2025-02-27BUY64873.18074.600 74.458USD 48,249 72.30
2025-02-26SELL-37574.30075.310 75.209USD -28,203 72.28 Loss of -1,099 on sale
2025-02-25SELL-7274.40076.240 76.056USD -5,476 72.25 Loss of -274 on sale
2025-02-24BUY7274.01074.360 74.325USD 5,351 72.23
2025-02-20SELL-93671.38071.520 71.506USD -66,930 72.24 Profit of 690 on sale
2025-02-19BUY28870.16071.430 71.303USD 20,535 72.27
2025-02-18BUY29471.27071.680 71.639USD 21,062 72.28
2025-02-13BUY8,20870.01072.690 72.422USD 594,440 72.36
2025-02-12BUY2,44869.05069.100 69.095USD 169,145 72.41
2025-02-11BUY2,02166.33068.690 68.454USD 138,346 72.49
2025-02-07BUY21674.13076.960 76.677USD 16,562 72.53
2025-02-06BUY2,88074.95075.490 75.436USD 217,256 72.49
2025-02-05BUY1,44075.26075.740 75.692USD 108,996 72.45
2025-02-04BUY1,08074.12074.920 74.840USD 80,827 72.43
2025-02-03SELL-6,26473.74075.000 74.874USD -469,011 72.41 Loss of -15,438 on sale
2025-01-31BUY57674.16075.180 75.078USD 43,245 72.38
2025-01-30BUY7273.77074.560 74.481USD 5,363 72.36
2025-01-29BUY1,22473.72074.110 74.071USD 90,663 72.34
2025-01-28BUY43273.15073.990 73.906USD 31,927 72.33
2025-01-27BUY43272.64073.430 73.351USD 31,688 72.32
2025-01-24BUY43272.59073.680 73.571USD 31,783 72.32
2025-01-23BUY1,22472.53072.880 72.845USD 89,162 72.31
2025-01-22BUY72072.41073.550 73.436USD 52,874 72.31
2025-01-21BUY4,24873.47073.980 73.929USD 314,050 72.29
2025-01-17BUY86471.93073.000 72.893USD 62,980 72.30
2025-01-15BUY43272.46073.830 73.693USD 31,835 72.30
2025-01-13BUY1,22472.37072.940 72.883USD 89,209 72.30
2025-01-10BUY93770.54072.600 72.394USD 67,833 72.34
2024-12-31BUY21669.07069.200 69.187USD 14,944 72.44
2024-12-30SELL-5,26768.42068.870 68.825USD -362,501 72.53 Profit of 19,493 on sale
2024-12-27BUY1,39669.23069.900 69.833USD 97,487 72.60
2024-12-23BUY43269.84070.190 70.155USD 30,307 72.81
2024-12-20SELL-9,91568.84069.110 69.083USD -684,958 72.91 Profit of 37,917 on sale
2024-12-19BUY94867.06068.640 68.482USD 64,921 73.06
2024-12-17BUY71569.40069.740 69.706USD 49,840 73.30
2024-12-16BUY23769.80070.880 70.772USD 16,773 73.40
2024-12-13BUY39568.55070.790 70.566USD 27,874 73.54
2024-12-11BUY23772.49073.500 73.399USD 17,396 73.57
2024-12-10BUY15872.48073.100 73.038USD 11,540 73.60
2024-12-09BUY15872.11075.980 75.593USD 11,944 73.65
2024-12-05SELL-47474.92075.370 75.325USD -35,704 73.53 Loss of -849 on sale
2024-12-04BUY8074.62075.320 75.250USD 6,020 73.50
2024-12-02BUY31673.24074.700 74.554USD 23,559 73.56
2024-11-29BUY1,40474.59076.080 75.931USD 106,607 73.52
2024-11-27BUY31275.45076.140 76.071USD 23,734 73.36
2024-11-26BUY78074.80074.950 74.935USD 58,449 73.30
2024-11-25BUY9,67273.52073.870 73.835USD 714,132 73.29
2024-11-22BUY23471.72072.000 71.972USD 16,841 73.36
2024-11-21BUY23470.39071.400 71.299USD 16,684 73.51
2024-11-20BUY1,01471.05071.680 71.617USD 72,620 73.64
2024-11-19SELL-1,01470.56074.100 73.746USD -74,778 73.81 Profit of 65 on sale
2024-11-18BUY4,68076.97077.010 77.006USD 360,388 73.62
2024-11-12BUY93680.58082.020 81.876USD 76,636 73.19
2024-11-11BUY23481.53083.540 83.339USD 19,501 72.63
2024-11-08BUY94083.38083.950 83.893USD 78,859 71.87
2024-11-07BUY1,58482.34082.970 82.907USD 131,325 71.06
2024-11-06BUY70280.95082.190 82.066USD 57,610 70.24
2024-11-05BUY15677.28077.370 77.361USD 12,068 69.60
2024-11-04BUY80575.75076.570 76.488USD 61,573 68.98
2024-11-01BUY39076.13076.330 76.310USD 29,761 68.19
2024-10-30BUY23173.93074.600 74.533USD 17,217 66.52
2024-10-29BUY1,46373.60074.070 74.023USD 108,296 65.34
2024-10-25BUY30865.07065.740 65.673USD 20,227 65.32
2024-10-24BUY23165.24065.910 65.843USD 15,210 65.34
2024-10-22BUY46265.59065.780 65.761USD 30,382 65.27
2024-10-21BUY38565.27066.550 66.422USD 25,572 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19321,923395451,11071.4%
2025-09-18244,9471,423469,74752.1%
2025-09-17277,858779546,95350.8%
2025-09-16359,781946576,37962.4%
2025-09-15347,4534582,22859.7%
2025-09-12353,0400631,53455.9%
2025-09-11448,7333,894739,70160.7%
2025-09-10490,727248671,93273.0%
2025-09-09515,3951,822682,79175.5%
2025-09-08308,184119479,82864.2%
2025-09-05256,7192,505512,04950.1%
2025-09-04422,6241,507834,71750.6%
2025-09-03381,6797,777624,92261.1%
2025-09-02547,12015,396816,26767.0%
2025-08-29148,294262304,42748.7%
2025-08-28164,0080347,48047.2%
2025-08-27248,926453513,40148.5%
2025-08-26365,1306709,32051.5%
2025-08-25478,1301,306642,31974.4%
2025-08-22344,3522,023596,30157.7%
2025-08-21198,7294,881335,30159.3%
2025-08-20351,6993,977555,34563.3%
2025-08-19343,1103,146574,32859.7%
2025-08-18366,1244,996653,10356.1%
2025-08-15480,8858,035625,79776.8%
2025-08-14593,55436,654806,06873.6%
2025-08-13845,18198,1601,257,50367.2%
2025-08-12462,89642,208678,68968.2%
2025-08-11385,211696595,89264.6%
2025-08-08248,925738426,18758.4%
2025-08-07268,864929420,48663.9%
2025-08-06554,642891731,48475.8%
2025-08-05361,6872,092623,87958.0%
2025-08-04338,0051,464519,15065.1%
2025-08-01414,814828572,87972.4%
2025-07-31570,8456,148777,41773.4%
2025-07-30471,30314,166881,19453.5%
2025-07-29966,64010,5811,593,70160.7%
2025-07-28382,23662625,51061.1%
2025-07-25216,96749422,99051.3%
2025-07-24348,27623528,51765.9%
2025-07-23297,903583487,29761.1%
2025-07-22267,987172446,48960.0%
2025-07-21223,626380406,72955.0%
2025-07-18241,218108471,58951.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.